The aim of this study is a genome analysis for the characterization of individual metastatic KIT exon 11-mutant GIST, to better understand the range of additional aberrations occurring in each tumor and eventually find simultaneous molecular events that are responsible for tumor progression and may represent potential new drug target candidates. The gene discussed is KIT; the disease is neoplasm.